ethiopian pharmaceuticals supply agency · 2020. 9. 18. · ethiopian pharmaceuticals supply agency...

Ethiopian Pharmaceuticals Supply Agency

Tender Management Directorate Annual Procurement Plan 2013/2014 EFY

Prepared by

Prepared by

Seifu Isa, Director, Tender Management, EPSA

Dan Victor Ojwando, Senior Technical Advisor, Procurement

and Contracts Management (Global)

Solomon Berhie Tekle, National Technical Advisor,

Procurement and Contracts

April 2020

April 2020

Forward

This document is an annual procurement plan of the Ethiopian Pharmaceuticals

Supply Agency for the 2013 Ethiopian Fiscal Year which defines the appropriate goods

(pharmaceuticals products, lab chemical and reagents and medical equipment) that

the agency will obtain from local and international suppliers.

The purpose of the document is to inform the list of required goods, to estimate the

forecasted expenses and to define the tendering procedures and implementation

timelines. This procurement plan helps the agency define its procurement

requirements and to decide where and when to procure.

Consistent with the Federal Public Procurement Proclamation 649/2009 Chapter

Three-Section 22, Public bodies shall have to prepare an annual procurement plan

showing their procurement for the concerned budget year and containing such

details are stated in the directive to be issued by the Minister.

The procurement plan shall have to be approved by the head of the public body

concerned and communicated to the relevant departments of the public body and the

Agency until Hamle 30 of the Ethiopian Calendar.

In light of fairness and transparency the procurement plans shall be published and

made available to the general public. Through publication of the Procurement Plans,

interested bidders can be made aware of the upcoming tenders and thus have ample

time to prepare themselves accordingly.

By publishing the plans, the public is also made aware of the different activities to be

undertaken by the agency within the specified year and in turn it gives a clearer

picture of public spending.

Goitom Gigar

Inbound Deputy Director General

Acknowledgement

The Ethiopian Pharmaceuticals Supply Agency (EPSA) would like to acknowledge all

contributors for their effort in developing this annual procurement plan for 2013 EFY.

The agency further expresses its immense appreciations to PSA staff for their

workforce capacity support to ensure this plan to success with the required quality.

The agency would like to extend its gratitude once again to Pamela Steele Associates

(PAS) under the Admas program for their professional, technical, and financial

support throughout the development of this document.

Finally, the agency would also like to thank to the following persons who contributed

a lot to this Procurement plan:

- Mr.Goitom Gigar, Inbound Deputy Director General, EPSA

- Mr. Seifu Isa, Tender Management Directorate, EPSA

- Mr. Tibebu Hailu, Tender Management Medicine Program Coordinator, EPSA

- Mr. Abyot Adane, Tender Management Medicine Revolving Drug Fund

Coordinator, EPSA

- Mr. Walta Tekle, Tender Management Medical Equipment Coordinator, EPSA

- Ms. Hilina Tesfaye, Tender Management Chemical and Medical Supplies

Coordinator, EPSA

- Mr. Abrahale Beyene, Tender Management Medical Equipment Officer, EPSA

- Mr. Teketel Ahadu, Tender Management Medicine Program Officer, EPSA

- Mr. Damtew Negash, Tender Management Chemical and Medical Supplies

officer, EPSA

- Mr. Dan Oluoch, Procurement Technical Advisor, PSA

- Mr. Solomon Berhie Tekle, Procurement Technical Advisor, PSA

Abbreviation

EFY Ethiopian Fiscal Year

EPSA Ethiopian Supply Agency

DDG Deputy Director General

PPP Public Procurement Plan

PSA Pamela Steele Associates

RDF Revolving Drug Fund

SDP Service Delivery Point

Table of Contents Introduction ............................................................................................................................................ 6

Background ............................................................................................................................................. 6

Advantage of the procurement plan ...................................................................................................... 7

Objectives ............................................................................................................................................... 8

Scope ....................................................................................................................................................... 8

Purpose ................................................................................................................................................... 8

Legal Framework that supports Annual procurement planning ............................................................. 9

Source of Funds ....................................................................................................................................... 9

Supply Plan and Budget Allocation ......................................................................................................... 9

Procurement Method and their applications ......................................................................................... 9

Activities ............................................................................................................................................ 10

Challenges and mitigation measures .................................................................................................... 11

Risk Management ................................................................................................................................. 11

Special Procurement Methods ............................................................................................................. 18

Large Value Procurement ................................................................................................................. 18

Procedure of Framework Contract ................................................................................................... 18

Publication of Annual Procurement Plan .............................................................................................. 19

Conclusions ........................................................................................................................................... 20

Introduction

The Procurement Plan is an annual document which defines the products and

services that a Public Body will obtain from external suppliers. A sound procurement

plan helps a Procuring Entity to define their procurement requirements and to decide

what, when where and how to procure.

EPSA being a public institution, its procurement and contract management is

governed by procurement legal frameworks (Proclamation 649/2009, Directive 8th

June 2010 and Manual 2011) issued by PPA. Tender management directorate must

ensure total compliance with the provisions and conditions of the legal frameworks.

Annual Procurement planning is one of the critical process that each public

Institution is required to undertake to ensure annually the needs to sustain their

operations are planned through annual procurement planning processes. This

process must be aligned with available resource to ensure delivery of required

services to general public. Tender management always ensure proper planning of

requirements for EPSA to ensure that EPSA constantly delivers services expected of

them by the government and the general public. Procurement planning at EPSA is a

complex process that requires proper and advance planning since it involves so

many stakeholders internally and externally that relies a lot on EPSA services.

Tender management therefore must work very closely with the key stakeholders to

ensure annual procurement planning processes is achieved and necessary

approvals granted before implementation of the plan.

Background Pursuant to section 22 of Proclamation 649/2009 and section 8 (Part III) of the

Directive June 2010 on procurement planning provides for the following.

1) Public bodies shall have to prepare an annual procurement plan showing

their procurement for the concerned budget year and containing such

details as are stated in the directive to be issued by the Minister.

2) The procurement plan to be prepared by public bodies in accordance with

sub-article (1) of this Article, shall have to be approved by the head of the

public body concerned and communicated to the relevant departments of

the public body and the Agency until Hamle 30 of the Ethiopian Calendar.

3) Any Public Body and other entities accountable to such Public Body shall be

required to prepare a procurement plan supported by action plan enabling

them to execute in due time, the procurement necessary to implement their

work program.

In view of the above conditions, tender management directorate

commenced annual procurement planning for EPSA requirements for

financial year 2013. This process was commenced through a workshop in

Adama with all key stakeholder present to ensure the objectives of the

workshop is achieved. The workshop focused on review of legal

frameworks to a certain the condition and provisions of the same,

documentation used for planning as provided by the legal frameworks and

risk identification associated with the planning processes & mitigation

measures.

Advantage of the procurement plan

The advantages of the procurement planning process are as follows:

• Strong alignments and cooperation with key stakeholders

• Economies of scale are gained by uniting the requirements of different

areas to achieve better deals

• There are no surprises when requirements manifest

• Everyone can plan and schedule resources more effectively.

• Periodic indicative notices can be published based on the procurement

plan

• The procurement plan is linked to the strategic plan of the agency

Objectives Pursuant to section 8 (Part III) of the Directive June 2010 on procurement planning

provides for the following.

1. The procurement plan shall be prepared in such a way as to enable the

attainment of the following objectives: -

a) To ensure compliance with principles of public procurement stated in

article 5 of the Proclamation.

b) To achieve the work program of the Public Body.

c) To ensure economy and efficiency in the operation of the Public Body by

discouraging piecemeal purchase.

d) Exercise prudence and make the necessary preparation to forestall

problems that might be encountered in the execution of procurement.

EPSA Tender management directorate will ensure that the stated objectives

are achieved during development and implementation of the annual

procurement planning.

Scope The annual procurement planning will focus on procurement of Medical Supplies,

Laboratory Reagents & Chemicals, Medicines and Medical Equipment’s for both RDF

and Program items. All the items under RDF must in the approved EPSA procurement

list consideration with National Essential Medicine List and items for stock.

Program commodities and capital medical equipment annual forecast and plan will

be done in collaborations with Ministry of Health and stakeholders respectively.

Purpose The main purpose of the annual procurement planning process is to ensure all

requirements from all key stakeholders are properly planned for and acquired during

the financial year for respective use and increase coordination of service delivery at

all SDP’s by ensure constant supply of Medical commodities.

Legal Framework that supports Annual procurement planning EPSA being a public institution within the Federal Government its procurement

processes are governed by the following legal frameworks:

Proclamation 649/2009

Directive June 2010

Manual 2011

Financial Management Act (Proclamation 648/2009), (970/2016)

Audit & Governance Act (Proclamation No 649/2010), (982/2016)

Tender Management team must ensure total compliance with provisions and

conditions of the state legal frameworks during annual procurement planning and

implementation without breach.

Source of Funds The procurement of all health commodities in view of EPSA Procurement List will be

based on the following sources of funds:

Revolving Drug Fund (RDF): This will focus on stock items where EPSA

warehouse and distribute at a cost recovery through mark ups.

Program Based Fund: This focus on non-stock items-based service

oriented in line with donor program requirements which EPSA stock

and distribute for free.

Supply Plan and Budget Allocation Tender management adopted items for annual procurement planning based upon

approved supply plan with proper budget, right procurement items in compliance

with procurement list and required approval from respective EPSA management.

Procurement Method and their applications Pursuant to section 15 (Part IV) of the Directive June 2010 on methods of procurement

to be used during planning provides for the following.

15.1 The following procurement methods are approved as per article 33 of the

Proclamation.

a) Open bidding

b) Restricted bidding

c) Request for quotations

d) Single source/ direct procurement

e) Request for proposal, and

f) Two stage bidding

15.2 Except as otherwise provided in the Proclamation and this Directive, public

bodies shall use

open bidding as the preferred procedure of procurement.

15.3 Public bodies may use a method other than open bidding only where

conditions for use

of such other method stipulated in the Proclamation and this Directive are

satisfied.

15.4 A Public Body using a method of procurement other than open bidding

pursuant to article

33/3 of the Proclamation. Shall record a statement of the grounds and

circumstances on

which it relied to justify the use of that method.

Activities A. Individual Plans from each coordinator

B. Consolidated Procurement (RDF & Program)

C. Implementation Plan

D. Risk Management Plan

1. Approval and Amendment of procurement plan, consolidated plan,

implementation plan & risk mitigation plan

Pursuant to section 8 (Part III) of the Directive June 2010 on approval and amendment

of procurement planning provides for the following.

1. Procurement units of public bodies have to submit the annual procurement

plan they

have prepared to the head of the Public Body for approval after consultation

with the Procurement Endorsing Committee of the Public Body.

2. The head of a Public Body has to monitor the execution of procurement by

establishing a

system enabling him to ascertain that the conduct of procurement

conforms to the approved procurement plan.

3. The head of a Public Body shall send a copy of the approved annual

procurement plan to

the appropriate departments and the Agency for implementation and follow

up in accordance with the provision of article 22/2 of the proclamation.

4. Public Body shall not split procurements nor deviate from the annual

procurement plan once it is approved by the head of the Public Body and a

copy of it is sent to the Agency.

5. Notwithstanding the provision of sub article 4 of this article, a Public Body

may at any time modify its procurement plan where necessary.

6. A procurement plan modified in accordance with sub article 5 of this article

shall be sent to those departments and the Agency for which the initial

procurement plan was sent.

In view of the above conditions, each coordinator will ensure their

respective plans are ready, examined by Director Procurement, cleared by

Deputy Director General inbound, Reviewed by Tender Endorsement

committee and approved by Director General. Tender Management will only

implement approved annual procurement plan that has been endorsed by

EPSA Executive Committee and Board of Directors.

Challenges and mitigation measures

Registration

Un planned procurement requests

Complaint

Foreign currency

Custom and bank, and another stakeholder’s cooperativeness

Global scenario API price shoot

Risk Management

Risk Possible

Consequences Possible Solutions

Critical procurement activity

Failure to secure accurate

information or data at the

Demand and Supply Planning.

Failure to achieve

key organizational

results

Develop market knowledge

Identify alternative sources

and extra due diligences to

Total costs of

procurement too high

check he capacity of

suppliers

Plan in advanced

Work closely with

beneficiary/ partner to be

aware of rapid changes of

needs

Apply contractual penalties

and remedies

Selection of procurement Strategy

Selection of inappropriate

procurement strategy

Inadequate or

inappropriate results

Not achieving best

value for money

Damage procurement

implementation

Agree on desired

outcomes/objectives and

have a clear understanding

of the project objectives

Develop a good

understanding of

associated risks in order to

incorporate them into

procurement strategies

development

Planning

Lack of planning

Delay in task

implementation

Inadequate supplier

response

Procurement

process shortcuts

Higher prices

Early involvement of

procurement officers in

project planning

Develop and communicate

an accurate Requisition

Plan

Insufficient lead-time

Inadequate supplier

response

Procurement

process shortcuts

Higher prices

Involve procurement

officers in the project

planning phase

Delay requisitions to create false

emergencies

Claims of unethical

or unfair dealings

Delay of project

implementation

Higher total cost of

acquisition

Not achieving Best

Value for Money

Early involvement of

procurement officers in

project implementation

Seek proper justification of

emergencies

Training of requisitioners

Requirements definition

Restrictive

specifications/TOR/SOW

Inadequate suppliers’

response

Limits competition

Lack of transparency

Developed market and

product understanding

Include generic functional

and performance

specifications

Apply relevant international

standards where applicable

Inadequate


Significant variety in

offers received

Insufficient

responses

Offer of

goods/services that

do not meet needs

Difficulty in

evaluating competing

offers

Become familiar with

requirements of the

specification/TOR/SOW

Developed market and

product understanding

External support

(consultant) to developed

specifications/TOR/ SOW

linked to clear deliverables

and target time

Do not include quality

requirements in


Impossibility to

achieve best value

for money

Difficulty in

comparison and

overall evaluation

Poor quality of the

procured items,

which may lead to a

waste of funds

Include quality in the

specifications/TOR/SOW,

using international and

national standards

If quality is a critical issue,

extra due diligence must be

used (i.e., check

manufacturing process and

standards, factory visits,

sampling and independent

laboratory analysis, pre-

shipment inspection, etc.)

Sourcing

Wrong approach to market

Inadequate or

inappropriate

supplier response

Higher prices

Selection of

inappropriate

approach

Analyse supply market

Develop sourcing

strategies

Identify wrong sourcing strategy

or do not have sourcing strategy

Inadequate or

inappropriate

supplier response

Limit competition

Proper application of the

pre-qualification or post-

qualification, depending on

the identified complexity

and risk

Misrepresentation of facts by

potential suppliers

Contract with

unsuitable

companies

Claims of unethical

or unfair dealing

Breach of contract

Independently verify

suppliers’ qualifications

Conduct supplier reference

check and due diligences

Outdated information on potential

suppliers

Inadequate suppliers’

response

Limit competition

Maintain suppliers’ roster

Advertisement of procurement

notices in inappropriate media

Lack of sourcing

strategy

Limit competition

Contract with

unsuitable

companies

Identify relevant media to

post procurement notices

Preparation and issuance of Bid documents

Use of inappropriate evaluation

criteria

Inadequate or

inappropriate results

Have clear goal to be

achieved as a result of the

procurement process

Not achieving best

value for money

Re-tendering (time/

cost)

Consider implications of

evaluation criteria

Unacceptable requirements to

suppliers

Loading the cost in

offers

Limits competition

Too few bids

Re-tendering

(time/cost)

Develop strong

understanding of market

and industry practices

Develop commercially

acceptable terms

Check that responsibility

for risks is not allocated to

suppliers for factors

outside their control

Provisions of inadequate

information

Loading cost in offers

Great variation in

offers

Create confusion

among potential

suppliers

Re-tendering

(time/cost)

Review documents before

issue

Know the market

Receipt and Evaluation

Failure to observe effective

evaluation procedures

Lack of fair

treatment of

suppliers

Inconsistency in

evaluation of offers

Subjectivity in

outcome of the

evaluations

Composition of the

evaluation team in line with

the project scope and

complexities

For high tech/highly

complex procurement

activities, ensure technical

expertise

Ensure staff are suitably

trained and experienced

Failure of offers to meet project

needs Need to re-tender

Ensure that specifications

are understandable,

generic, and in line with

what exists in the market

Know the marketplace

Failure of evaluation to identify a

clear winner, leading to

subjective discussions or

development of “new criteria”

Claims of unethical

and unfair behaviour

Need to re-tender

Ensure that selection

criteria are appropriate and

aligned with the project

needs

Selection of inappropriate

supplier

Failure of the

supplier to fulfil the

contract

Waste of funds

Contract disputes

Re-tendering

(time/cost)

Reject offers from

unacceptable suppliers and

document rationale for the

rejection

Develop clear evaluation

criteria aligned with the

project needs

Perform technical and

financial checks on

suppliers before awarding

the contract

Select inappropriate goods/

service

Failure of

goods/services to

meet the project

needs

Waste of funds

Re-tendering

(time/cost)

Develop proper

specifications/ TOR/SOW

Have the right technical

expertise during the

evaluation process

Ensure users are involved

Insufficient number of responses

Need to start the

procurement again

Delays to

procurement

schedule

Lack of value for

money due to limited

competition

Develop strong

understanding of market

Foster international

competition

Develop supplier rosters

Allow for sufficient time for

suppliers to prepare offers

Procurement Review and Award

Contract approval not obtained

Delay in the contract

award

Need to re-bid

(time/cost)

Proper procurement risk

analysis

Undermine business

community trust

Proper procurement

strategies (including

sourcing strategies)

Market understanding

Proper procurement

planning

Clear, generic and

complete

specifications/TOR/ SOW

Foster international

competition

Ensure adherence

throughout process to

rules, regulations and

procedures

Ensure adequate

documentation of process

and submission

Contract management

Unstructured or non-existent

contract management function

Not achieving best

value for money

Poor performance of

suppliers

Delivery delays

Possible cost

variation

Contract disputes

Identify resources for

contract managements

Develop structures for

contract management,

including clear roles and

responsibilities

Identify the right profile and

competences for contract

management

Develop contract

management plans

Failure by either party to fulfil the

conditions of the contract

Contract disputes

Failure or partial

failure to satisfy the

project needs

Delays

Legal actions

Ensure proper contract

management

Contract monitoring,

including regular

inspections and progress

reports

Review past performance

records

Be proactive

Maintain accurate records

and documentations

Special Procurement Methods Pursuant to section 60, 61& 63 of Proclamation 649/2009 (Chapter Eleven) on special

procurement Methods provides for the following.

Large Value Procurement

1) There shall be established a central body, which shall be in charge of the execution of large value procurements having national significance procurements of supplies for which a demand is shown by more than one public body and sale of public property to be disposed of, by a regulation to be issued by the Council of Ministers.

2) The Minister shall identify and update the types of procurements to be executed on account of their national significance by the central body which shall be established pursuant to sub article (1) of this Article.

Procedure of Framework Contract

1) Framework contracts may be used to fulfil similar procurement requirements

of various

Public bodies or recurrent procurement requirements of a public body.

2) The following procedure of framework contract shall be followed to meet similar

procurement requirements of public bodies within a given time frame:

a) the Agency shall undertake a survey of the similar requirements of public

bodies, issue a list of goods and services constituting such requirements

and update the list regularly.

b) public bodies shall prepare a forecast of their requirements of goods and

services falling under the list mentioned in sub-article (2) (a) of this

Article and communicate the same to the body authorized to conduct

large procurements.

c) the body to be established in accordance with Article 60(1) of this

Proclamation shall conclude and administer framework contracts in the

manner prescribed herein and the directive to be issued by the Ministry.

d) public bodies shall base on the framework contract signed by the central

body of procurement conclude the procurement by making order with the

suppliers of goods and services that they require.

e) the order that public bodies place with the suppliers for goods and

services of their requirements under the framework contract shall

confirm to the terms of the framework contract regarding price, terms of

payment and other matters related to the execution of procurement.

3) Except in cases provided for in Article 37 paragraph (k) of this Proclamation,

public bodies shall not be allowed to vary unit prices and such other

fundamental terms of the framework contract when placing order for goods

and services. However, the public body and the supplier may agree on terms

that have not been dealt with in the framework contract or that do not

materially affect the framework contract.

4) The framework contract shall be awarded through open bidding procedure and

may remain valid for three years.

5) In procuring goods and services under a framework contract to fulfill their

recurrent requirements, public bodies shall have to adhere to the criterion of

fixing prices of goods and services to be determined in the directive to be

issued by the Minister.

Tender management directorate in view of the above, will adopt both methods and

deploy based on the conditions outlined above, currently TMD is undertaking both

large volume and framework agreements approach under strategic sourcing

requirements. Framework agreement and large volume has proved to enable EPSA

start reducing on lead time management and encourage private sector to participate

in procurement process competitively thus improving on health commodity

availability and affordability.

Publication of Annual Procurement Plan Pursuant to section 8 (Part III) of the Directive June 2010 on approval and amendment

of procurement planning provides for the following.

The Agency may compile the annual procurement plans submitted to it by public

bodies in accordance with article 13/3 of this Directive, and as necessary, publish

procurement plans the value of which exceed the threshold specified in article 6/5 of

this Directive by assorting such plans by type of procurement, or facilitate the use by

public bodies of its website to post such procurement plans.

In compliance with the provision above, Tender management directorate will publish

the approved procurement plan in accordance with the provisions above. TMD will

not only comply to legal framework provisions but also ensure constant

communication to PPA and public on the plan is achieved.

2. Value preposition of annual procurement plan

Conclusions

This procurement plan helps to define the list of the required products that the agency

is going to purchase with a clear implementation plans in lined with the public

procurement proclamation 649/2009 to ensure the good procurement principles and

practices.

RDF Health Commodities

Every year EPSA collects health commodities demand from health facilities, the demand information will be conducted and processed through its hubs. The

collected data further analysed and correlated with the stock on hand, on pipelines and past consumption records, this succeed with quantification exercise

for the upcoming year.

Similarly, the annual procurement plan of 2013 E.C. is prepared after passing through a series discussions, cross checking, and consultations. Following the

annual procurement plan, some the commodities will be refilled from the signed framework agreement.

Other commodities will be procured pertinent to their market nature i.e. if there are only one manufacture the solicitation will be done through direct

contracting and if the commodities are available on local market with additional supply the award will be determined after nationally competing the local

bidders. Notwithstanding the above preconditions the selection of bidder will be done through floating in international tender.

Based on the above scenarios the RDF health commodities annual procurement plan for the Ethiopian FY is provided in the below table.

Annex 1. RDF commodities Pharmaceuticals Procurement Request (May 2020)

S/

N

o

Co

de

Goods, Services and

Works to be

Procured

Unit Quanti

ty

Curr

ency

Unit

Price

in

USD

Total

price

Source of Budget for

procurement

Procur

ement

Catego

ry*

Estimated

Budget for

Procuremen

t **

Selecte

d

Procur

ement

Metho

d ***

Estimated time

to Procure

Trea

sury

Inte

rnal

Reve

nue

Lo

an

A

id

Recu

rrent

Cap

ital

From

Purcha

se

reques

t up to

signed

Contra

ct Sent

to

CMD

From

Recei

ving

Signe

d

Contr

act up

to

Recei

ving

of

Good

s

1 2 3 4 5 6

7.00

8.00 9 10 11 12 13 14 15 16 17 18

1 Sali-11

Acetylsalicylic Acid - 81mg - Tablet (Enteric Coated)

20x10

71,373

USD

0.82

58,262.65

RDF Medicines

ICB 140 Days

110 Dyas

2 Acyc-32

Acyclovir - 500mg - Powder for injection

Each

2,633 USD

2.99

7,872.67

RDF Medicines

ICB 140 Days

110 Dyas

3 Alpr-11

Alprazolam - 0.5mg – Tablet

10x3

1,159

USD

0.86

990.95

RDF Medicines

ICB 140 Days

110 Dyas

4 Alms-21

Aluminium Hydroxide + Magnesium Hydroxide + Simethicone - (225mg + 200mg + 50mg)/5ml – Suspension

200ml

1,093,2

50

USD

0.64

701,197.6

5 RDF

Medicines

ICB 140 Days

110 Dyas

5 Amit-11

Amitriptyline - 25mg – Tablet

25x10

147,12

5 USD

0.82

120,642.5

0 RDF

Medicines

ICB 140 Days

110 Dyas

6 Amox-21

Amoxicillin - 250mg/5ml - Oral Suspension

100ml

2,023,6

20 USD

0.53

1,082,588

.26 RDF

Medicines

ICB 140 Days

110 Dyas

7 Amox-2

Amoxicillin - 500mg – Capsule

50X10

324,51

6 USD

11.96

3,881,351

.61 RDF

Medicines

ICB 140 Days

110 Dyas

8

Amcl-30

Amoxicillin + Clavulanic Acid - (500mg + 100mg) in Vial- Powder for Injection 10

4,934

USD

5.51

27,186.34

RDF Medicines

ICB 140 Days

110 Dyas

9 Ampi-21

Ampicillin - 250mg/5ml - Oral Suspension

100ml

144,83

8 USD

0.54

77,695.99

RDF Medicines

ICB 140 Days

110 Dyas

10 Ampi-02

Ampicillin - 500mg – Capsule

50X10

58,975

USD

15.27

900,771.4

9 RDF

Medicines

ICB 140 Days

110 Dyas

11 Ampi-31

Ampicillin Sodium - 500mg in Vial - Injection

50

128,196 USD

3.03

387,795.4

6 RDF

Medicines

ICB 140 Days

110 Dyas

12 Cfce-60

Anti-haemorrhoidal (Hydrocortisone + Framycetin+ Cinchocaine + Esculoside) - (5mg + 10mg + 5mg ) - Suppository

10

45,954

USD

1.37

62,956.98

RDF Medicines

ICB 140 Days

110 Dyas

13 Aten-11

Atenolol - 50mg – Tablet

10x10

25,378

USD

0.80

20,346.44

RDF Medicines

ICB 140 Days

110 Dyas

14 Ator-12

Atorvastatin - 40mg – Tablet

10x3

103,031 USD

5.56

572,522.6

6 RDF

Medicines

ICB 140 Days

110 Dyas

15 Atro-30

Atropine Sulfate - 1mg/ml in 1ml ampoule - Injection

10x10

20,000

USD

6.76

135,296.0

0 RDF

Medicines

ICB 140 Days

110 Dyas

16 Azel-51

Azelaic Acid - 20% - Cream

30gm

13,615 USD

5.35

72,777.62

RDF Medicines

ICB 140 Days

110 Dyas

17 Azit-20

Azithromycin - 200mg/5ml - Oral Suspension

15ml

75,302 USD

0.36

27,289.44

RDF Medicines

ICB 140 Days

110 Dyas

18 Azit-11

Azithromycin - 500mg – Tablet

10x3

135,354 USD

2.56

347,178.9

1 RDF

Medicines

ICB 140 Days

110 Dyas

19 Becp-41

Beclomethasone Dipropionate - 100mcg/dose - Aerosol (Oral Inhalation)

200 Me-

tered dose

42,874

USD

1.76

75,458.24

RDF Medicines

ICB 140 Days

110 Dyas

20 Besa-56

Benzoic Acid + Salicylic Acid - (6% + 3%) - Topical Ointment

20gm

220,884 USD

0.38

83,715.50

RDF Medicines

ICB 140 Days

110 Dyas

21 Betd-50

Betamethasone Dipropionate - 0.03% - Cream

15gm

131,647 USD

0.58

75,697.03

RDF Medicines

ICB 140 Days

110 Dyas

22 calg-30

Calcium gluconate - 10% in 10ml Ampoule - Injection

10

10,624 USD

0.87

9,232.26

RDF Medicines

ICB 140 Days

110 Dyas

23 Cast-20

Castor oil – Liquid 60ml

62,033 USD

0.85

52,455.10

RDF Medicines

ICB 140 Days

110 Dyas

24 Ceft-30

Ceftazidime - 0.5g in Vial - Powder for injection

Each

50,906 USD

0.30

15,373.61

RDF Medicines

ICB 140 Days

110 Dyas

25 Cefr-31

Ceftriaxone - 0.5g in Vial - Powder for Injection with 5ml Diluent

Each

358,515

USD

0.15

53,777.25

RDF Medicines

ICB 140 Days

110 Dyas

26 Amph-42

Chloramphenicol - 0.5% - Eye/Ear drop

10ml

198,000 USD

0.29

57,420.00

RDF Medicines

ICB 140 Days

110 Dyas

27 amde-40

Chloramphenicol - 0.5% + Dexamethasone 0.1% - Eye Drop

10ml

208,259

USD

0.24

50,315.37

RDF Medicines

ICB 140 Days

110 Dyas

28 Phen-20

Chlorpheniramine Maleate - 2mg/5ml - Syrup

100ml

169,57

9 USD

0.21

35,221.56

RDF Medicines

ICB 140 Days

110 Dyas

29 Phen-11

Chlorpheniramine Maleate - 4mg - Tablet

10x10

69,190

USD

0.55

38,124.44

RDF Medicines

ICB 140 Days

110 Dyas

30 Cpzn-13

Chlorpromazine Hydrochloride - 100mg - Tablet

100x10

12,852

USD

6.93

89,025.71

RDF Medicines

ICB 140 Days

110 Dyas

31 Cpzn-11


1000

8,685 USD

5.69

49,374.50

RDF Medicines

ICB 140 Days

110 Dyas

32 Cpzn-30

Chlorpromazine Hydrochloride - 25mg/2ml in 2ml Ampoule - Injection

50

6,227 USD

5.47

34,038.03

RDF Medicines

ICB 140 Days

110 Dyas

33 Cime-31

Cimetidine - 100mg/ml in 2ml ampoule - Injection

10

525,087 USD

0.76

396,440.6

9 RDF

Medicines

ICB 140 Days

110 Dyas

34 Cime-11

Cimetidine - 400mg – Tablet

10x10

129,59

9 USD

1.72

222,770.3

6 RDF

Medicines

ICB 140 Days

110 Dyas

35 Cipr-10

Ciprofloxacin - 250mg – Tablet

10x10

59,374

USD

1.22

72,701.59

RDF Medicines

ICB 140 Days

110 Dyas

36 Cipr-11


10x10

689,24

0 USD

2.09

1,443,560

.80 RDF

Medicines

ICB 140 Days

110 Dyas

37 Cist-30

Cisatracurium- 2mg/ml in 10 ml Ampoule - Injection

Each

6,362 USD

11.02

70,128.33

RDF Medicines

ICB 140 Days

110 Dyas

38 Clot-62

Clotrimazole - 500mg - Tablet (Vaginal)

6

3,776 USD

0.30

1,140.35

RDF Medicines

ICB 140 Days

110 Dyas

39 Clox-21

Cloxacillin Sodium - 250mg/5ml - Oral Suspension

100ml

330,37

9 USD

0.54

178,671.2

3 RDF

Medicines

ICB 140 Days

110 Dyas

40 Clox-02

Cloxacillin Sodium - 500 mg – Capsule

50X10

178,70

1 USD

14.72

2,630,974

.53 RDF

Medicines

ICB 140 Days

110 Dyas

41 Cloz-12

Clozapine - 100mg – Tablet

10x5

3,708 USD

7.31

27,099.55

RDF Medicines

ICB 140 Days

110 Dyas

42 Dexa-10

Dexamethasone - 0.5mg – Tablet

10x10

239,03

0 USD

3.74

895,119.5

4 RDF

Medicines

ICB 140 Days

110 Dyas

43 Dext-22

Dextromethorphan Hydro bromide - 15mg/5ml - Syrup

125ml

636,12

7 USD

0.40

253,148.1

5 RDF

Medicines

ICB 140 Days

110 Dyas

44 DW40-34

Dextrose - 40% in 20ml - Intravenous Infusion

50

122,717 USD

2.25

276,126.3

1 RDF

Medicines

ICB 140 Days

110 Dyas

45 Dime-11

Dimenhydrinate - 50mg – Tablet

10x10

18,180

USD

2.05

37,334.45

RDF Medicines

ICB 140 Days

110 Dyas

46 Diph-20

Diphenhydramine Hydrochloride - 12.5mg/5ml - Elixir

125ml

584,65

1 USD

0.28

163,631.2

4 RDF

Medicines

ICB 140 Days

110 Dyas

47 Doxy-01

Doxycycline - 100mg – Capsule

20x10

257,79

8 USD

2.30

592,023.1

3 RDF

Medicines

ICB 140 Days

110 Dyas

48 Enal-12

Enalapril Maleate - 10mg - Tablet

10x10

391,50

1 USD

1.87

733,046.4

7 RDF

Medicines

ICB 140 Days

110 Dyas

49 Enal-11

Enalapril Maleate - 5mg – Tablet

10x10

234,56

7 USD

1.24

290,228.8

4 RDF

Medicines

ICB 140 Days

110 Dyas

50 Eryt-20

Erythromycin - 125 mg/5 ml - Oral Suspension

100ml

27,000

USD

1.39

37,508.40

RDF Medicines

ICB 140 Days

110 Dyas

51 Eryt-11

Erythromycin Stearate - 500mg – Tablet

10x10

51,899

USD

5.54

287,300.5

8 RDF

Medicines

ICB 140 Days

110 Dyas

52 Heam-20

Ferrics Ammonium Citrate+ Folic Acid + Cyanocobalamin+ Cupric sulfate + Manganese sulfate - (160mg+0.5mg+7.5mcg+30mcg+30mcg) /5ml- Syrup

100ml

96,546

USD

2.43

234,606.7

8 RDF

Medicines

ICB 140 Days

110 Dyas

53 Fesu-11

Ferrous Sulfate - 325mg – Tablet

10x10

22,528

USD

0.66

14,777.58

RDF Medicines

ICB 140 Days

110 Dyas

54 Fesu-25

Ferrous Sulfate - 75mg/0.6ml - Oral Drop

30ml

10,214 USD

0.10

1,024.36

RDF Medicines

ICB 140 Days

110 Dyas

55 Conf-12

Fluconazole - 200mg – Tablet

10x10

23,435 USD

2.63

61,606.33

RDF Medicines

ICB 140 Days

110 Dyas

56 Fuci -50

Fluocinolone Acetonide - 0.025% - Cream

10gm

79,998 USD

0.29

22,972.78

RDF Medicines

ICB 140 Days

110 Dyas

57 Fluo -01

Fluoxetine - 20mg – Capsule

10x2

137,495 USD

0.59

81,172.74

RDF Medicines

ICB 140 Days

110 Dyas

58 Foli-13

Folic Acid - 5mg – Tablet

10x10

21,969 USD

3.46

76,089.55

RDF Medicines

ICB 140 Days

110 Dyas

59 Frus-11

Furosemide - 40mg – Tablet

10x10

133,47

9 USD

0.78

104,290.8

1 RDF

Medicines

ICB 140 Days

110 Dyas

60 Glib-10

Glibenclamide - 5mg – Tablet

10x10

365,72

6 USD

0.52

191,922.8

2 RDF

Medicines

ICB 140 Days

110 Dyas

61 Gris-11

Griseofulvin - 250mg – Tablet

10x10

47,549

USD

3.10

147,164.1

6 RDF

Medicines

ICB 140 Days

110 Dyas

62 Guai-20

Guaifenesin - 100mg/5ml – Syrup

100ml

143,22

8 USD

0.40

57,833.03

RDF Medicines

ICB 140 Days

110 Dyas

63 Hald-30

Haloperidol Decanoate - 50mg/ml in 1ml Ampoule - Injection (Depot, oily)

5

4,725 USD

6.49

30,679.43

RDF Medicines

ICB 140 Days

110 Dyas

64 Halo-45

Halothane – Inhalation 250m

l

18,156 USD

15.00

272,340.0

0 RDF

Medicines

ICB 140 Days

110 Dyas

65 Thia-11

Hydrochlorothiazide - 25mg – Tablet

10x10

329,87

6 USD

0.75

248,123.9

6 RDF

Medicines

ICB 140 Days

110 Dyas

66 Cort-56

Hydrocortisone Acetate - 1% - Topical Ointment

15gm

340,951 USD

0.39

134,191.1

9 RDF

Medicines

ICB 140 Days

110 Dyas

67 Hyos-11

Hyoscine (Scopolamine) Butyl bromide - 10mg - Tablet

10x10

46,300

USD

3.20

148,076.4

2 RDF

Medicines

ICB 140 Days

110 Dyas

68 Ibup-12

Ibuprofen - 400mg – Tablet

10x10

519,35

0 USD

0.99

514,192.9

3 RDF

Medicines

ICB 140 Days

110 Dyas

69 Icht-56

Ichthammol - 10% - Topical Ointment

20gm

78,458 USD

0.35

27,448.38 RDF

Medicines

ICB 140 Days

110 Dyas

70 Indo-01

Indomethacin - 25mg – Capsule

10x10

175,20

5 USD

1.16

203,040.1

4 RDF

Medicines

ICB 140 Days

110 Dyas

71 Keto-50

Ketoconazole - 2% - Cream

20gm

395,703 USD

0.27

106,839.8

1 RDF

Medicines

ICB 140 Days

110 Dyas

72 Keto-10

Ketoconazole - 200mg – Tablet

10x10

29,383

USD

1.86

54,653.14

RDF Medicines

ICB 140 Days

110 Dyas

73 Lora-10

Loratadine - 10mg - Tablet

10x10

31,979

USD

1.15

36,779.87

RDF Medicines

ICB 140 Days

110 Dyas

74 Mebe-20

Mebendazole - 100mg/5ml - Oral Suspension

30ml

405,224 USD

0.16

66,157.86

RDF Medicines

ICB 140 Days

110 Dyas

75 Metf-10

Metformin - 500mg – Tablet

10x10

418,60

2 USD

0.87

363,554.9

7 RDF

Medicines

ICB 140 Days

110 Dyas

76 Dopm-10

Methyldopa - 250mg – Tablet 100x

10

4,913

USD

28.70

141,003.1

0 RDF

Medicines

ICB 140 Days

110 Dyas

77 Pram-20

Metoclopramide - 0.2mg/drop - Oral Drop

15ml

287,980 USD

0.39

113,342.9

2 RDF

Medicines

ICB 140 Days

110 Dyas

78 Pram-11

Metoclopramide - 10mg - Tablet

10x10

79,651

USD

0.22

17,416.09

RDF Medicines

ICB 140 Days

110 Dyas

79 Pram-21

Metoclopramide - 5mg/5ml – Syrup

60ml

150,959 USD

0.40

59,634.36

RDF Medicines

ICB 140 Days

110 Dyas

80 Metr-20

Metronidazole - 125mg/5ml - Oral Suspension

100ml

1,081,8

54 USD

0.32

346,944.1

9 RDF

Medicines

ICB 140 Days

110 Dyas

81 Metr-01

Metronidazole - 250mg – Capsule

100x10

119,57

9 USD

6.73

804,616.6

3 RDF

Medicines

ICB 140 Days

110 Dyas

82 Muvi-20

Multivitamin - Syrup 120m

l

150,14

3 USD

0.42

63,060.06

RDF Medicines

ICB 140 Days

110 Dyas

83 Nife-12

Nifedipine - 20mg – Tablet

10x10

264,21

0 USD

0.77

203,353.4

1 RDF

Medicines

ICB 140 Days

110 Dyas

84 Norf-10

Norfloxacin - 400mg – Tablet

10x10

111,42

0 USD

2.18

243,235.6

8 RDF

Medicines

ICB 140 Days

110 Dyas

85 Omep-02

Omeprazole - 20 mg - Capsule (Enclosing Enteric Coated Granules)

10x10

867,95

4 USD

0.85

736,356.2

6 RDF

Medicines

ICB 140 Days

110 Dyas

86 Omep-30

Omeprazole - 4mg/ml in 10ml – Injection

Each

386,088 USD

1.09

419,754.8

7 RDF

Medicines

ICB 140 Days

110 Dyas

87 Orsp-26

Oral Rehydration Salt - 20.7g for 1 Litre Preparation - Powder

Sachet

2,747,9

91 USD

0.06

157,025.3

1 RDF

Medicines

ICB 140 Days

110 Dyas

88 Para-20

Paracetamol - 120mg/5ml – Syrup

60ml

1,620,000 USD

0.22

349,498.2

6 RDF

Medicines

ICB 140 Days

110 Dyas

89 Para-13

Paracetamol - 500mg – Tablet

100x10

171,35

1 USD

4.37

749,335.2

9 RDF

Medicines

ICB 140 Days

110 Dyas

90 Pent-30

Pentazocine - 30mg/ml in 1 ampoule - Injection

10

1,062 USD

12.17

12,925.18

RDF Medicines

ICB 140 Days

110 Dyas

91 Perm-55

Permethrin - 0.05 – Cream

30gm

112,292 USD

0.42

47,477.06

RDF Medicines

ICB 140 Days

110 Dyas

92 Barb-13

Phenobarbitone (Phenobarbital) - 100mg - Tablet

100x10

45,642

USD

7.14

325,742.4

5 RDF

Medicines

ICB 140 Days

110 Dyas

93 Barb-11


1000

12,466 USD

3.06

38,106.04

RDF Medicines

ICB 140 Days

110 Dyas

94 Hyda-36

Phenytoin (Diphenhydantoin) Sodium - 250mg - Powder for injection

Each

6,812 USD

2.84

19,337.91

RDF Medicines

ICB 140 Days

110 Dyas

95 Pipe-22

Piperazine Citrate - 700mg/5ml – Elixir

29ml

133,031 USD

0.12

16,172.87

RDF Medicines

ICB 140 Days

110 Dyas

96 Pred-13

Prednisolone - 5 mg – Tablet

100x10

23,018

USD

8.31

191,247.3

8 RDF

Medicines

ICB 140 Days

110 Dyas

97 Prom-10

Promethazine HCL - 25mg – Tablet

100x10

6,576

USD

5.39

35,467.60

RDF Medicines

ICB 140 Days

110 Dyas

98 Prom-20

Promethazine HCL - 5mg/5ml – Elixir

100ml

20,251

USD

0.82

16,512.67

RDF Medicines

ICB 140 Days

110 Dyas

99 Prtu-12

Propylthiouracil - 100mg - Tablet (Scored)

100

129,206 USD

8.42

1,088,174

.24 RDF

Medicines

ICB 140 Days

110 Dyas

100

Rani-10

Ranitidine - 150mg – Tablet

10x10

15,409 USD

1.22

18,867.83

RDF Medicines

ICB 140 Days

110 Dyas

101

Salb-10

Salbutamol (Albuterol) - 2mg – Tablet

10x10

57,730

USD

0.52

30,042.64

RDF Medicines

ICB 140 Days

110 Dyas

102

Salb-20

Salbutamol (Albuterol) - 2mg/5ml - Syrup

100ml

117,62

8 USD

0.28

32,578.61

RDF Medicines

ICB 140 Days

110 Dyas

103

Sert-11

Sertraline HCL - 100mg – Tablet

10x10

2,736

USD

10.60

29,002.15

RDF Medicines

ICB 140 Days

110 Dyas

104

Snak-30

Snake Venom Antiserum Polyvalent - Injection 10ml

13,518

USD

34.80

470,426.4

0 RDF

Medicines

ICB 140 Days

110 Dyas

105

Socr-40

Sodium Cromoglycate - 2% - Eye Drop

10ml

21,230 USD

0.38

8,067.40

RDF Medicines

ICB 140 Days

110 Dyas

106

Stib-30

Sodium Stibogluconate - 33% W/V - Injection

100ml

1,915 USD

8.15

15,614.91

RDF Medicines

ICB 140 Days

110 Dyas

107

Sodb-30

Sodium Bicarbonate - 8.4%w/v in 25ml ampoule- Injection 50

1,134

USD

163.47

185,374.9

8 RDF

Medicines

ICB 140 Days

110 Dyas

108

Valp-10

Sodium Valproate - 200mg - Tablet (enteric coated)

10x10

153,20

8 USD

2.07

317,140.5

6 RDF

Medicines

ICB 140 Days

110 Dyas

109

Sutr-20

Sulphamethoxazole + Trimethoprim - (200mg +40mg)/5ml - Suspension

100ml

1,132,4

14 USD

0.30

335,096.2

4 RDF

Medicines

ICB 140 Days

110 Dyas

110

Sutr-11

Sulphamethoxazole + Trimethoprim - (400mg +80mg) - Tablet

100x10

32,324

USD

8.45

273,005.8

0 RDF

Medicines

ICB 140 Days

110 Dyas

111

Sulp-51

Sulphur - 10% - Ointment

50gm

489,929 USD

0.38

188,540.8

1 RDF

Medicines

ICB 140 Days

110 Dyas

112

Tini-10

Tinidazole - 500 mg – Tablet

60x4

63,392

USD

3.15

199,684.8

0 RDF

Medicines

ICB 140 Days

110 Dyas

113

Cain-40

Tetracaine - 0.5% - Eye Drop

10ml

8,537 USD

1.45

12,375.24

RDF Medicines

ICB 140 Days

110 Dyas

114

Epth-10

Theophylline + Ephedrine - (120mg + 11mg) - Tablet

100x10

12,754

USD

5.08

64,847.19

RDF Medicines

ICB 140 Days

110 Dyas

115

Vbbb-10

Vitamin B1 + Vitamin B6 + Vitamin B12 - (100mg +200mg + 1000mcg) - Tablet

10x10

199,67

4 USD

2.55

509,168.7

0 RDF

Medicines

ICB 140 Days

110 Dyas

116

Vbbb-30

Vitamin B1 + Vitamin B6 + Vitamin B12 -

3

93,952

USD

0.45

42,654.21

RDF Medicines

ICB 140 Days

110 Dyas

(100mg +100mg +1000mcg) - Injection

117

Wars-11

Warfarin Sodium - 5mg – Tablet

10x10

40,059

USD

2.53

101,349.2

7 RDF

Medicines

ICB 140 Days

110 Dyas

118

Wate-31

Water For Injection - 10ml – Injection

100

36,847 USD

1.76

64,701.34

RDF Medicines

ICB 140 Days

110 Dyas

119

Petr-56

White Petrolatum – Ointment

50gm

102,73

0 USD

0.41

42,119.30

RDF Medicines

ICB 140 Days

110 Dyas

120

Petr-57


1Kg

9,897 USD

6.56

64,920.88

RDF Medicines

ICB 140 Days

110 Dyas

121

Zinc-50

Zinc Oxide 15% Cream 20gm

125,424 USD

0.50

62,710.90

RDF Medicines

ICB 140 Days

110 Dyas

122

Sali-14

Acetylsalicylic Acid - 300mg - Tablet (Micro fined)

10x10

337,20

3 ETB

13.14

4,429,498

.61 RDF

Medicines

NCB 90 days 110 Dyas

123

Sali-11

Acetylsalicylic Acid - 81mg - Tablet (Enteric Coated)

20x10

71,373

ETB

28.00

1,998,444

.00 RDF

Medicines


124

Acyc-10

Acyclovir - 200mg – Capsule

10x10

13,937

ETB

63.46

884,387.8

1 RDF

Medicines


125

Albe-20

Albendazole - 100mg/5ml - Oral Suspension

20ml

470,907 ETB

6.40

3,013,804

.80 RDF

Medicines


126

Albe-11

Albendazole - 400mg – Tablet

50x2

76,001 ETB

80.47

6,115,800

.47 RDF

Medicines


127

Alms-21

Aluminium Hydroxide + Magnesium Hydroxide + Simethicone - (225mg

200ml

1,093,2

50 ETB

22.00

24,051,50

0.00 RDF

Medicines


+ 200mg + 50mg)/5ml – Suspension

128

Alma-10

Aluminium Hydroxide + Magnesium Trisilicate - (120mg + 250mg) - Tablet (Chewable)

100x10

27,629

ETB

126.10

3,484,016

.90 RDF

Medicines


129

Amox-21

Amoxicillin - 250mg/5ml - Oral Suspension

100ml

2,023,6

20 ETB

18.35

37,133,42

7.00 RDF

Medicines


130

Amox-2

Amoxicillin - 500mg – Capsule

50X10

324,51

6 ETB

410.25

133,132,6

89.00 RDF

Medicines


131

Ampi-21

Ampicillin - 250mg/5ml - Oral Suspension

100ml

144,83

8 ETB

18.40

2,665,019

.20 RDF

Medicines


132

Ampi-02

Ampicillin - 500mg – Capsule

50X10

58,975

ETB

523.90

30,897,00

2.50 RDF

Medicines


133

Aten-11

Atenolol - 50mg – Tablet

10x10

25,378

ETB

27.50

697,895.0

0 RDF

Medicines


134

Ator-11

Atorvastatin - 20mg – Tablet

10x10

67,732

ETB

150.00

10,159,80

0.00 RDF

Medicines


135

Azit-11

Azithromycin - 500mg – Tablet

10x3

135,354 ETB

87.98

11,908,44

4.92 RDF

Medicines


136

Besa-56

Benzoic Acid + Salicylic Acid - (6% + 3%) - Topical Ointment

20gm

220,884 ETB

13.00

2,871,492

.00 RDF

Medicines


137

Phen-11

Chlorpheniramine Maleate - 4mg - Tablet

10x10

69,190

ETB

18.90

1,307,691

.00 RDF

Medicines


138

Cpzn-13


100x10

12,852

ETB

237.60

3,053,635

.20 RDF

Medicines


139

Cpzn-11


1000

8,685 ETB

195.00

1,693,575

.00 RDF

Medicines


140

Cime-11

Cimetidine - 400mg – Tablet

10x10

129,59

9 ETB

58.96

7,641,157

.04 RDF

Medicines


141

Cipr-10


10x10

59,374

ETB

42.00

2,493,708

.00 RDF

Medicines


142

Cipr-11


10x10

689,24

0 ETB

71.84

49,515,00

1.60 RDF

Medicines


143

Clox-21

Cloxacillin Sodium - 250mg/5ml - Oral Suspension

100ml

330,37

9 ETB

18.55

6,128,530

.45 RDF

Medicines


144

Clox-02

Cloxacillin Sodium - 500 mg – Capsule

50X10

178,70

1 ETB

505.00

90,244,00

5.00 RDF

Medicines


145

Dext-22

Dextromethorphan Hydro bromide - 15mg/5ml - Syrup

125ml

636,12

7 ETB

13.65

8,683,133

.55 RDF

Medicines


146

DW40-34

Dextrose - 40% in 20ml - Intravenous Infusion

50

122,717 ETB

77.18

9,471,298

.06 RDF

Medicines


147

Diph-20

Diphenhydramine Hydrochloride - 12.5mg/5ml - Elixir

125ml

584,65

1 ETB

9.60

5,612,649

.60 RDF

Medicines


148

Doxy-01

Doxycycline - 100mg – Capsule

20x10

257,79

8 ETB

78.77

20,306,74

8.46 RDF

Medicines


149

Enal-11

Enalapril Maleate - 5mg – Tablet

10x10

234,56

7 ETB

42.44

9,955,023

.48 RDF

Medicines


150

Eryt-11

Erythromycin Stearate - 500mg – Tablet

10x10

51,899

ETB

189.88

9,854,582

.12 RDF

Medicines


151

Heam-20

Ferrics Ammonium Citrate+ Folic Acid + Cyanocobalamin+ Cupric sulfate + Manganese sulfate - (160mg+0.5mg+7.5mcg+30mcg+30mcg) /5ml- Syrup

100ml

96,546

ETB

83.20

8,032,627

.20 RDF

Medicines


152

Fesu-11

Ferrous Sulfate - 325mg – Tablet

10x10

22,528

ETB

22.50

506,880.0

0 RDF

Medicines


153

Fesu-25

Ferrous Sulfate - 75mg/0.6ml - Oral Drop

30ml

10,214 ETB

3.44

35,136.16

RDF Medicines


154

Conf-12

Fluconazole - 200mg – Tablet

10x10

23,435

ETB

90.17

2,113,133

.95 RDF

Medicines


155

Fuci -50

Fluocinolone Acetonide - 0.025% - Cream

10gm

79,998 ETB

9.85

787,980.3

0 RDF

Medicines


156

Fluo -01

Fluoxetine - 20mg – Capsule

10x2

137,495 ETB

20.25

2,784,273

.75 RDF

Medicines


157

Foli-13

Folic Acid - 5mg – Tablet

10x10

21,969

ETB

118.80

2,609,917

.20 RDF

Medicines


158

Frus-11

Frusemide - 40mg – Tablet

10x10

133,47

9 ETB

26.80

3,577,237

.20 RDF

Medicines


159

Glib-10

Glibenclamide - 5mg – Tablet

10x10

365,72

6 ETB

18.00

6,583,068

.00 RDF

Medicines


160

Gris-10

Griseofulvin - 125mg – Tablet

10x10

23,402

ETB

57.70

1,350,295

.40 RDF

Medicines


161

Gris-20

Griseofulvin - 125mg/5ml - Oral Suspension

100ml

11,000

ETB

46.31

509,410.0

0 RDF

Medicines


162

Guai-20

Guaifenesin - 100mg/5ml – Syrup

100ml

143,22

8 ETB

13.85

1,983,707

.80 RDF

Medicines


163

Thia-11

Hydrochlorothiazide - 25mg – Tablet

10x10

329,87

6 ETB

25.80

8,510,800

.80 RDF

Medicines


164

Cort-56

Hydrocortisone Acetate - 1% - Topical Ointment

15gm

340,951 ETB

13.50

4,602,838

.50 RDF

Medicines


165

Hyos-11

Hyoscine (Scopolamine) Butyl bromide - 10mg - Tablet

10x10

46,300

ETB

109.70

5,079,110

.00 RDF

Medicines


166

Ibup-12

Ibuprofen - 400mg – Tablet

10x10

519,35

0 ETB

33.96

17,637,12

6.00 RDF

Medicines


167

Icht-56

Ichthammol - 10% - Topical Ointment

20gm

78,458 ETB

12.00

941,496.0

0 RDF

Medicines


168

Indo-01

Indomethacin - 25mg – Capsule

10x10

175,20

5 ETB

39.75

6,964,398

.75 RDF

Medicines


169

Keto-10

Ketoconazole - 200mg – Tablet

10x10

29,383

ETB

63.80

1,874,635

.40 RDF

Medicines


170

Lora-10

Loratadine - 10mg - Tablet

10x10

31,979

ETB

39.45

1,261,571

.55 RDF

Medicines


171

Mebe-10

Mebendazole - 100mg – Tablet

40x6

59,152 ETB

46.70

2,762,398

.40 RDF

Medicines


172

Mebe-20

Mebendazole - 100mg/5ml - Oral Suspension

30ml

405,224 ETB

5.60

2,269,254

.40 RDF

Medicines


173

Metf-10

Metformin - 500mg – Tablet

10x10

418,60

2 ETB

29.79

12,470,15

3.58 RDF

Medicines


174

Sali-56

Methyl salicylate - 25% - Ointment

20gm

116,560 ETB

11.70

1,363,752

.00 RDF

Medicines


175

Pram-20

Metoclopramide - 0.2mg/drop - Oral Drop

15ml

287,980 ETB

13.50

3,887,730

.00 RDF

Medicines


176

Pram-11

Metoclopramide - 10mg - Tablet

10x10

79,651

ETB

7.50

597,382.5

0 RDF

Medicines


177

Pram-21

Metoclopramide - 5mg/5ml – Syrup

60ml

150,959 ETB

13.55

2,045,494

.45 RDF

Medicines


178

Metr-20

Metronidazole - 125mg/5ml - Oral Suspension

100ml

1,081,8

54 ETB

11.00

11,900,39

4.00 RDF

Medicines


179

Metr-01

Metronidazole - 250mg – Capsule

100x10

119,57

9 ETB

230.80

27,598,83

3.20 RDF

Medicines


180

Nife-12

Nifedipine - 20mg – Tablet

10x10

264,21

0 ETB

26.40

6,975,144

.00 RDF

Medicines


181

Norf-10

Norfloxacin - 400mg – Tablet

10x10

111,42

0 ETB

74.88

8,343,129

.60 RDF

Medicines


182

Omep-02

Omeprazole - 20 mg - Capsule (Enclosing Enteric Coated Granules)

10x10

867,95

4 ETB

29.10

25,257,46

1.40 RDF

Medicines


183

Orsp-26

Oral Rehydration Salt - 20.7g for 1 Litre Preparation - Powder

Sachet

2,747,9

91 ETB

1.96

5,386,062

.36 RDF

Medicines


184

Para-20

Paracetamol - 120mg/5ml – Syrup

60ml

1,620,000 ETB

7.40

11,988,00

0.00 RDF

Medicines


185

Para-13

Paracetamol - 500mg – Tablet

100x10

171,35

1 ETB

150.00

25,702,65

0.00 RDF

Medicines


186

Barb-13


100x10

45,642

ETB

244.80

11,173,16

1.60 RDF

Medicines


187

Barb-11


1000

12,466 ETB

104.85

1,307,060

.10 RDF

Medicines


188

Pipe-22

Piperazine Citrate - 700mg/5ml – Elixir

29ml

133,031 ETB

4.17

554,739.2

7 RDF

Medicines


189

Pred-13

Prednisolone - 5 mg – Tablet

100x10

23,018

ETB

284.99

6,559,899

.82 RDF

Medicines


190

Prom-10

Promethazine HCL - 25mg – Tablet

100x10

6,576

ETB

185.00

1,216,560

.00 RDF

Medicines


191

Prtu-12

Propylthiouracil - 100mg - Tablet (Scored)

100

129,206 ETB

288.88

37,325,02

9.28 RDF

Medicines


192

Rani-10

Ranitidine - 150mg – Tablet

10x10

15,409

ETB

42.00

647,178.0

0 RDF

Medicines


193

Ring-31

Ringer's Solution - Each contains Na+ 147mEq + K+4mEq Cl-155mEq - Intravenous Infusion with Giving Set

1000ml

1,872,4

82

ETB

24.40

45,688,56

0.80 RDF

Medicines


194

Salb-10

Salbutamol (Albuterol) - 2mg – Tablet

10x10

57,730

ETB

17.85

1,030,480

.50 RDF

Medicines


195

Salb-20

Salbutamol (Albuterol) - 2mg/5ml - Syrup

100ml

117,62

8 ETB

9.50

1,117,466

.00 RDF

Medicines


196

Sodc-33

Sodium Chloride (Normal Saline) - 0.009 - Intravenous Infusion with Giving Set

1000ml

6,912,5

06 ETB

20.40

141,015,1

22.40 RDF

Medicines


197

Sutr-20

Sulphamethoxazole + Trimethoprim - (200mg +40mg)/5ml - Suspension

100ml

1,132,4

14 ETB

10.15

11,494,00

2.10 RDF

Medicines


198

Sutr-11

Sulphamethoxazole + Trimethoprim - (400mg +80mg) - Tablet

100x10

32,324

ETB

289.70

9,364,262

.80 RDF

Medicines


199

Sulp-51

Sulphur - 10% - Ointment

50gm

489,929 ETB

13.20

6,467,062

.80 RDF

Medicines


200

Tini-10

Tinidazole - 500 mg – Tablet

60x4

63,392

ETB

108.00

6,846,336

.00 RDF

Medicines


201

Epth-10

Theophylline + Ephedrine - (120mg + 11mg) - Tablet

100x10

12,754

ETB

174.40

2,224,297

.60 RDF

Medicines


202

Wate-31

Water For Injection - 10ml – Injection

100

36,847 ETB

60.23

2,219,294

.81 RDF

Medicines


203

Petr-56


50gm

102,73

0 ETB

14.00

1,438,220

.00 RDF

Medicines


204

Petr-57


1Kg

9,897 ETB

225.00

2,226,825

.00 RDF

Medicines


205

Zinc-50

Zinc Oxide 15% Cream 20

gm

125,42

4 ETB

17.15

2,151,021

.60 RDF

Medicines


206

Azol-11

Acetazolamide - 250mg – Tablet

10x10

6,534 USD

2.65

17,315.10

RDF Medicines

Framework

35-45 Days

110 Days

207

Adre-30

Adrenaline (Epinephrine) - 0.1% in 1ml ampoule –Injection

Each

839,207

USD

0.50

419,603.5

0 RDF

Medicines

Framework

35-45 Days

110 Days

208

Amcl-20

Amoxicillin + Clavulanic Acid - (125mg +31.25mg)/5ml - Oral Suspension

100ml

247,49

4 USD

0.67

164,583.5

1 RDF

Medicines

Framework

35-45 Days

110 Days

209

Amcl-14

Amoxicillin + Clavulanic Acid - (500mg + 125mg) - Tablet (Film Coated)

5x3

1,435,570

USD

0.83

1,184,345

.25 RDF

Medicines

Framework

35-45 Days

110 Days

210

Amcl-12

Amoxicillin + Clavulanic Acid - 250mg + 125mg - Tablet (Film Coated)

10x2

131,831

USD

0.98

129,589.8

7 RDF

Medicines

Framework

35-45 Days

110 Days

211

Bepl-55

Anti-haemorrhoidal (Betamethasone Valer- ate + Phenylephrine HCl + Lidocaine HCl) - (0.5mg+1mg+25mg) – Ointment

20gm

135,142

USD

0.60

80,814.92

RDF Medicines

Framework

35-45 Days

110 Days

212

Betd-56

Betamethasone Dipropionate - 0.05% - Ointment

20gm

60,122 USD

0.45

27,054.90

RDF Medicines

Framework

35-45 Days

110 Days

213

Bupi-32

Bupivacaine 0.5% in 10ml injection

5

71,581 USD

3.00

214,743.0

0 RDF

Medicines

Framework

35-45 Days

110 Days

214

Carb-20

Carbamazepine - 100mg/5ml – Syrup

100ml

3,945

USD

3.13

12,347.85

RDF Medicines

Framework

35-45 Days

110 Days

215

Carb-11

Carbamazepine - 200mg – Tablet

10x10

86,707

USD

4.08

353,764.5

6 RDF

Medicines

Framework

35-45 Days

110 Days

216

Cefe-31

Cefepime - 1gm in Vial - Powder for Injection with Solvent Water for Injection*

Each

59,019

USD

0.56

33,050.64

RDF Medicines

Framework

35-45 Days

110 Days

217

Cefr-32

Ceftriaxone - 1g in vial - Powder for Injection with 10ml Diluent

Each

6,762,807 USD

0.19

1,255,853

.26 RDF

Medicines

Framework

35-45 Days

110 Days

218

Ceph-20

Cephalexin - 125mg/5ml - Oral Suspension

100ml

266,11

4 USD

0.38

101,123.3

2 RDF

Medicines

Framework

35-45 Days

110 Days

219

Ceti-11

Cetirizine - 10mg - Tablet

10x10

17,047 USD

0.36

6,171.01

RDF Medicines

Framework

35-45 Days

110 Days

220

Cipr-40

Ciprofloxacin - 0.3% - Eye/Ear drop

5ml

114,757 USD

0.11

12,623.27

RDF Medicines

Framework

35-45 Days

110 Days

221

Dexa-40

Dexamethasone - 0.10% - Eye/Ear drop

10ml

239,030 USD

0.20

46,849.88

RDF Medicines

Framework

35-45 Days

110 Days

222

Fesu-20

Ferrous Sulfate - 125mg/5ml – Syrup

200ml

32,400

USD

0.40

12,960.00

RDF Medicines

Framework

35-45 Days

110 Days

223

Fusi-50

Fusidic Acid - 2% - Topical Cream

10g

ethiopian pharmaceuticals supply agency · 2020. 9. 18. · ethiopian pharmaceuticals supply agency...

Documents